MannKind Corp. (MNKD)
2.555
+0.06
(+2.20%)
USD |
NASDAQ |
Apr 06, 12:47
MannKind SG&A Expense (TTM) : 229.86M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| United Therapeutics Corp. | 645.00M |
| Amicus Therapeutics, Inc. | 383.49M |
| Keros Therapeutics, Inc. | 46.85M |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Ionis Pharmaceuticals, Inc. | 393.68M |